News · Endocrinology & Metabolism
432 stories
Aug 18, 26Amylyx eyes FDA filing for GLP-1 blocker after late-stage win in post-bariatric hypoglycemia
Aug 17, 26Amylyx readies approval push after GLP-1 inhibitor halves blood sugar crashes in ph. 3 win
Aug 14, 26After 2 undisclosed gene therapy deaths, can China’s alternative regulatory path still be trusted?
Aug 13, 26Zealand sells its rights to Takeda’s blood cancer drug for $100M ahead of FDA approval decision